P38 Hepatitis NSW's specialised counselling service: professional support for people undertaking DAA treatment for viral hepatitis C

P38 Hepatitis NSW's specialised counselling service: professional support for people undertaking DAA treatment for viral hepatitis C

Bibliographic Details
Main Authors:	L. Pesa, M. McMahon
Format:	Article
Language:	English
Published:	Elsevier 2017-08-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020307792

Similar Items

P67 Strategies supporting and increasing hepatitis C testing and treatment for people in NSW prisons
by: S. Wilkinson, et al.
Published: (2017-08-01)

Treatment of hepatitis C virus genotype 4 in the DAA era
by: Antonio Di Biagio, et al.
Published: (2018-11-01)

Antioxidants benefits in hepatitis C infection in the new DAAs era
by: Sonia A. Lozano-Sepúlveda, et al.
Published: (2019-05-01)

Effect of DAA therapy in hepatitis C treatment — an impulsive control approach
by: Amar Nath Chatterjee, et al.
Published: (2021-04-01)

Comparison of recording of hepatitis B infection in the NSW Perinatal Data Collection with linked hepatitis B notifications
by: Lucy Deng, et al.
Published: (2017-12-01)

Clinical application and management of DAA therapy for hepatitis C: an interpretation of 2015 AASLD guidelines for the management of hepatitis C
by: ZHANG Xiaxia, et al.
Published: (2015-11-01)

Where is the focus on hepatitis C research after the introduction of DAAs: To Understand, knowledge, prevent or cure hepatitis C?
by: Ana M. Rivas-Estilla, et al.
Published: (2020-03-01)

P57 Taking hepatitis C issues to the homes of Arabic communities in NSW
by: W. Sabri
Published: (2017-08-01)

The fourth wave in workplace counselling : towards the understanding and the development of the professional specialisation of workplace counselling
by: Claringbull, Norman
Published: (2006)

Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
by: Sylvia Drazilova, et al.
Published: (2018-01-01)

"Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
by: Neil Gupta, et al.
Published: (2017-01-01)

A Decade of Hepatitis C at the UCT/GSH Liver Clinic in the Pre-DAA era
by: Nordien, Rozeena
Published: (2020)

Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?
by: Annie Madden, et al.
Published: (2018-01-01)

O11 Hepatitis C: stigma indicators and patient reported outcome measures for DAA treatment
by: C. Treloar, et al.
Published: (2017-08-01)

A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil
by: Simone Monzani Vivaldini, et al.
Published: (2021-03-01)

O26 Primary care-based viral hepatitis clinic in rural NSW: outcomes from the first 15 months of direct acting agents
by: A.C. Balcomb
Published: (2017-08-01)

P5 Primary care-based viral hepatitis clinic in rural NSW: outcomes from the first 15 months of direct acting agents
by: A.C. Balcomb
Published: (2017-08-01)

Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
by: Haitham A. Azeem, et al.
Published: (2021-06-01)

Treatment of hepatitis C using direct-acting antiviral (DAA) agents in patients undergoing liver transplantation
by: V. E. Syutkin, et al.
Published: (2016-02-01)

CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
by: A. Budkowska
Published: (2018-12-01)

Serología en hepatitis virales = Serology in viral hepatitis
by: Jaramillo Aristizábal, María Clara, et al.
Published: (2011-03-01)

Barriers to optimal screening and vaccination of hepatitis B contacts: a survey of general practitioners in NSW, Australia
by: Zeina Najjar, et al.
Published: (2017-12-01)

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
by: D. E. Valutite, et al.
Published: (2018-12-01)

Hepatitis Virales
by: Julio Gerardo Mora Campos, et al.
Published: (2019-08-01)

LITERATURE REVIEW IN THE FIELD OF DAAS : DAAS RELATED SECURITY ISSUES IN CLOUD COMPUTING
by: MOHAN, ANEESHA
Published: (2012)

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
by: Loreta A Kondili, et al.
Published: (2017-01-01)

Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs
by: Ghada El Sagheer, et al.
Published: (2018-01-01)

Enterically Transmitted Viral Hepatitis: Hepatitis A and Hepatitis E
by: Phunchai Charatcharoenwitthaya
Published: (2020-07-01)

Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
by: Loreta A Kondili, et al.
Published: (2018-01-01)

Viral hepatitis and anaesthesiologist.
by: Anila D Malde
Published: (2004-01-01)

Hepatitis viral aguda
by: Héctor Rubén Hernández Garcés, et al.
Published: (1998-10-01)

Hepatitis viral C
by: Pedro A. Poma
Published: (2011-12-01)

Prevention of Viral Hepatitis
by: Neşe SALTOĞLU
Published: (2001-09-01)

Viral hepatitis today
by: Nožić Darko
Published: (2015-01-01)

Skrivbordsvirtualisering : VDI vs DaaS
by: Javani, Daniel, et al.
Published: (2015)

Vulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitis.
by: Fahimeh Bagheri Amiri, et al.
Published: (2014-01-01)

Management Of Patients With Hepatitis B Virus Reactivation Post–DAA Treatment Of Chronic Hepatitis C Virus Infection In HCV–HBV Coinfected Patients With Pretreatment HBeAg Seroconversion And Early Degree Of Hepatic Fibrosis
by: Osman HA, et al.
Published: (2019-09-01)

Viral Hepatitis Selected Issues of Pathogenesis and Diagnostics
Published: (2011)

On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era
by: Dana Busschots, et al.
Published: (2021-08-01)

Treatment of hepatitis C in HIV/HCV co-infected with direct-acting antiviral (DAA) regimens in a single clinic in Tripoli/Libya
by: N. Bousifi, et al.
Published: (2020-12-01)